Missing trials from regulatory document of methylphenidate for adults with attention-deficit/hyperactivity disorder: Response to Boesen et al

J Clin Epidemiol. 2022 May:145:185-186. doi: 10.1016/j.jclinepi.2021.12.020. Epub 2021 Dec 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Humans
  • Methylphenidate* / therapeutic use
  • Psychiatric Status Rating Scales

Substances

  • Methylphenidate